To clarify the prevalence and risk factors of cognitive impairment in patients with coronary heart disease (CHD) through a systematic review and meta-analysis, highlighting the implications for clinical practice.
Key Findings:
Cognitive impairment prevalence in CHD patients is 36.6% (95% CI 27.6%–45.7%).
Significant risk factors include age (OR: 1.10), history of stroke (OR: 1.99), smoking (OR: 3.05), diabetes (OR: 2.31), depression (OR: 1.67), and anxiety (OR: 2.03), indicating a strong association with cognitive decline.
No significant correlations found with education level, hypertension, systolic blood pressure, or HDL-C.
Interpretation:
Cognitive impairment is prevalent among CHD patients, particularly in high-risk groups such as the elderly, smokers, and those with comorbid conditions or negative emotions, necessitating targeted interventions.
Limitations:
Variability in measurement approaches for cognitive impairment may lead to inconsistent prevalence estimates.
Differences in study quality and sampling strategies may affect the reliability of prevalence estimates.
The dynamic nature of cognitive changes complicates assessment and interpretation of results.
Conclusion:
Healthcare professionals should identify high-risk groups early and implement targeted interventions, such as cognitive assessments and support programs, to prevent cognitive impairment in CHD patients.
Damon B. Dixon, MD, at Phoenix Children’s Cardiology, is the author to this EndoText chapter. Dr. Dixon brings nationally recognized expertise in pediatric cardiovascular risk assessment and non?invasive vascular imaging.